• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年痴呆症中胆碱能和γ-氨基丁酸系统的尸检研究。

A post-mortem study of the cholinergic and GABA systems in senile dementia.

作者信息

Rossor M N, Garrett N J, Johnson A L, Mountjoy C Q, Roth M, Iversen L L

出版信息

Brain. 1982 Jun;105(Pt 2):313-30. doi: 10.1093/brain/105.2.313.

DOI:10.1093/brain/105.2.313
PMID:7082992
Abstract

Choline acetyltransferase (ChAT) activity and gamma-aminobutyric acid (GABA) concentration were measured in 19 cerebral cortical areas and 22 subcortical areas of brains from 26 control and 25 histologically proven cases of Alzheimer's disease. Reduced ChAt activity was observed in all the cortical areas examined in the Alzheimer cases dying before the median age of 79 years. In the Alzheimer cases aged greater than 79 years at death, 7 out of the 9 frontal cortical areas had a normal ChAT activity when compared with controls. Significant reductions in GABA concentrations in the Alzheimer cases were confined to the temporal cortex. Significant reductions in ChAT activity in subcortical areas were confined to 8 of the 22 regions examined. Notably these included the septal nuclei and substantia innominata, the proposed origins of the cholinergic projections to the hippocampus and neocortex, respectively. There were no reductions in GABA concentrations outside the cerebral cortex. Four multi-infarct cases and 6 cases with normal histology were found to have a small reduction in ChAT activity confined to only a few areas. The data are consistent with a predominant loss in Alzheimer's disease of the diffuse cholinergic projection from the brainstem and basal forebrain.

摘要

在26例对照者以及25例经组织学证实的阿尔茨海默病患者的大脑中,对19个大脑皮质区域和22个皮质下区域的胆碱乙酰转移酶(ChAT)活性及γ-氨基丁酸(GABA)浓度进行了测量。在79岁中位数年龄之前死亡的阿尔茨海默病患者所检查的所有皮质区域中,均观察到ChAT活性降低。在死亡时年龄大于79岁的阿尔茨海默病患者中,与对照组相比,9个额叶皮质区域中有7个区域的ChAT活性正常。阿尔茨海默病患者GABA浓度的显著降低仅限于颞叶皮质。皮质下区域ChAT活性的显著降低仅限于所检查的22个区域中的8个。值得注意的是,这些区域包括隔核和无名质,它们分别是向海马体和新皮质投射胆碱能纤维的假定起源部位。大脑皮质以外的区域GABA浓度没有降低。发现有4例多发梗死病例和6例组织学正常的病例,其ChAT活性仅在少数几个区域有轻微降低。这些数据与阿尔茨海默病中脑干和基底前脑弥漫性胆碱能投射的主要丧失是一致的。

相似文献

1
A post-mortem study of the cholinergic and GABA systems in senile dementia.老年痴呆症中胆碱能和γ-氨基丁酸系统的尸检研究。
Brain. 1982 Jun;105(Pt 2):313-30. doi: 10.1093/brain/105.2.313.
2
Choline acetyltransferase immunohistochemistry in brains of Alzheimer's disease patients and controls.阿尔茨海默病患者及对照者大脑中胆碱乙酰转移酶免疫组化研究
Neurosci Lett. 1983 Apr 11;36(2):195-9. doi: 10.1016/0304-3940(83)90264-1.
3
Cholinergic enzymes in neocortex, hippocampus and basal forebrain of non-neurological and senile dementia of Alzheimer-type patients.非神经疾病患者及阿尔茨海默型老年痴呆症患者新皮层、海马体和基底前脑中的胆碱能酶。
Brain Res. 1983 May 16;267(2):281-91. doi: 10.1016/0006-8993(83)90880-6.
4
The substantia innominata in Alzheimer's disease: an histochemical and biochemical study of cholinergic marker enzymes.阿尔茨海默病中的无名质:胆碱能标记酶的组织化学和生物化学研究
Neurosci Lett. 1982 Feb 12;28(2):217-22. doi: 10.1016/0304-3940(82)90155-0.
5
Dementia with Lewy bodies: choline acetyltransferase parallels nucleus basalis pathology.路易体痴呆:胆碱乙酰转移酶与基底核病理学平行。
J Neural Transm (Vienna). 1999;106(5-6):525-35. doi: 10.1007/s007020050176.
6
Cortical somatostatin-like immunoreactivity in cases of Alzheimer's disease and senile dementia of the Alzheimer type.阿尔茨海默病及阿尔茨海默型老年痴呆症病例中的皮质生长抑素样免疫反应性
Neurobiol Aging. 1981 Spring;2(1):9-14. doi: 10.1016/0197-4580(81)90053-1.
7
Correlation of cortical cholinergic and GABA deficits with quantitative neuropathological findings in senile dementia.老年痴呆症中皮质胆碱能和GABA缺乏与定量神经病理学发现的相关性
Brain. 1984 Jun;107 ( Pt 2):507-18. doi: 10.1093/brain/107.2.507.
8
A comparison of brain choline acetyltransferase activity in Alzheimer's disease, multi-infarct dementia, and combined dementia.阿尔茨海默病、多发梗死性痴呆及混合性痴呆患者脑胆碱乙酰转移酶活性的比较
J Neural Transm. 1988;73(2):121-8. doi: 10.1007/BF01243383.
9
Correlation of choline acetyltransferase activity between the nucleus basalis of Meynert and the cerebral cortex.
Neurosci Res. 1987 Apr;4(4):330-6. doi: 10.1016/0168-0102(87)90050-2.
10
Reduced cortical choline acetyltransferase activity in senile dementia of Alzheimer type is not accompanied by changes in vasoactive intestinal polypeptide.阿尔茨海默型老年痴呆症患者大脑皮质中胆碱乙酰转移酶活性降低,但血管活性肠肽并未发生变化。
Brain Res. 1980 Nov 10;201(1):249-53. doi: 10.1016/0006-8993(80)90795-7.

引用本文的文献

1
Glutamatergic and GABAergic metabolite levels in Alzheimer's disease: a systematic review and meta-analysis.阿尔茨海默病中谷氨酸能和γ-氨基丁酸能代谢物水平:一项系统评价和荟萃分析。
BMC Neurol. 2025 Aug 26;25(1):344. doi: 10.1186/s12883-025-04375-2.
2
Neurophysiological correlates of modifiable dementia risk factors in cognitively unimpaired older adults.认知未受损的老年人中可改变的痴呆风险因素的神经生理学关联
Cereb Cortex. 2025 Aug 1;35(8). doi: 10.1093/cercor/bhaf179.
3
Hippocampal Interneurons Shape Spatial Coding Alterations in Neurological Disorders.
海马体中间神经元塑造神经疾病中的空间编码改变。
Mol Neurobiol. 2025 May 20. doi: 10.1007/s12035-025-05020-2.
4
Fueling Brain Inhibition: Integrating GABAergic Neurotransmission and Energy Metabolism.为大脑抑制提供能量:整合γ-氨基丁酸能神经传递与能量代谢
Neurochem Res. 2025 Apr 7;50(2):136. doi: 10.1007/s11064-025-04384-0.
5
Gut microbiota metabolites: potential therapeutic targets for Alzheimer's disease?肠道微生物群代谢产物:阿尔茨海默病的潜在治疗靶点?
Front Pharmacol. 2024 Sep 17;15:1459655. doi: 10.3389/fphar.2024.1459655. eCollection 2024.
6
Advances in Therapeutics to Alleviate Cognitive Decline and Neuropsychiatric Symptoms of Alzheimer's Disease.治疗阿尔茨海默病认知衰退和神经精神症状的新进展。
Int J Mol Sci. 2024 May 9;25(10):5169. doi: 10.3390/ijms25105169.
7
Gray matter gamma-hydroxy-butyric acid and glutamate reflect beta-amyloid burden at old age.灰质中的γ-羟基丁酸和谷氨酸反映了老年时的β-淀粉样蛋白负荷。
Alzheimers Dement (Amst). 2024 Apr 30;16(2):e12587. doi: 10.1002/dad2.12587. eCollection 2024 Apr-Jun.
8
The Unveiling of Therapeutic Targets for Alzheimer's Disease: An Integrative Review.阿尔茨海默病治疗靶点的揭示:综合述评。
Curr Top Med Chem. 2024;24(10):850-868. doi: 10.2174/0115680266282492240220101049.
9
Voltage-Gated Na Channels in Alzheimer's Disease: Physiological Roles and Therapeutic Potential.阿尔茨海默病中的电压门控钠通道:生理作用及治疗潜力
Life (Basel). 2023 Jul 29;13(8):1655. doi: 10.3390/life13081655.
10
The GABAergic system in Alzheimer's disease: a systematic review with meta-analysis.阿尔茨海默病中的 GABA 能系统:系统评价与荟萃分析。
Mol Psychiatry. 2023 Dec;28(12):5025-5036. doi: 10.1038/s41380-023-02140-w. Epub 2023 Jul 7.